Document is current
Any future updates will be listed below
-
Authors
Molimard, Mathieu
Kottakis, Ioannis
Jauernig, Juergen
Lederhilger, Sonja
Nikolaev, Ivan
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Accepted: 6 March 2021
First Online: 25 March 2021
Declarations
:
: This review was supported by Novartis Pharma AG, Basel, Switzerland.
: Mathieu Molimard is a full-time employee at the University of Bordeaux and the University Hospital of Bordeaux; he has also received fees for consultancy and participation in advisory boards for GSK, Novartis Pharma and Boehringer Ingelheim. Ioannis Kottakis, Juergen Jauernig, Sonja Lederhilger and Ivan Nikolaev are full-time employees with Novartis Pharma AG, Basel, Switzerland.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: MM: conceptualisation, reviewing, editing and visualisation. IK: conceptualisation, reviewing and editing. JJ: conceptualisation, reviewing and editing. SL: conceptualisation, reviewing and editing. IN: conceptualisation, original draft preparation, reviewing, editing and visualisation.
